Nikon Corp. has released a new FX-format telephoto zoom lens, AF-P Nikkor 70-300mm f/4.5-5.6E ED VR for full-frame D-SLR cameras. The lens employs a stepping motor to the AF drive to realise high speed and quiet shutter release, also important to videography. The lens is equipped with optical vibration reduction (VR) function giving about 4.5-step advantage. It is also equipped with a SPORT mode to photograph fast-moving subjects. The lens consists of 18 elements in 14 groups, including one ED (Extra-low Dispersion) element to correct chromatic aberrations. The closest shooting distance is 1.2m for the entire zoom. The lens is also designed as ‘antidust and antisplash’. The maximum diameter is 80.5mm, length 146m and weighs about 680g. Suggested list price: 94,000 yen.
Japan's leading printer and photocopier maker Konica Minolta Inc. announced at the company will be acquiring Ambry Genetic Corp. - a US diagnostic company, in a deal valued at up to USD 1 billion. This is one of the largest deals for Konica Minolta and the company will jointly carry out the acquisition with the funds provided by Innovation Network Corp of Japan. Konica Minolta, which has a market value of around $4 billion, will account for 60 percent of the investment and the Innovation Network Corp of Japan (INCJ) will provide for the remaining 40 percent. Both the companies intend to enter into the precision medicine segment which is expected to have a great potential for the treatment of cancer. KMI has its own diagnostic technique, utilising a High Sensitive Tissue Testing (HSTT) technology, while Ambry excels in genetic tests for breast, colon and cancers, heart and respiratory diseases, etc. Further, the company will combine its HSTT technology and Ambry's genetic diagnostic technology to offer high-standard cancer diagnostic services and aid the development of new reagents which will help produce new medicines. Talking about the acquisition, Shoei Yamana - Chief Executive Officer of Konica Minolta Inc., said, “Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual's genetic and biochemical makeup." The companies expect to complete the necessary procedure for the deal by the end of October, 2017 and post which, Ambry will become a subsidiary of KMI while Ambry's business will be continued in the US.
Konica Minolta and Screen Graphic Solutions (Screen GA) have strengthened their collaboration in the commercial digital printing area. The companies plan to promote hybrid workflows and increase user-friendliness in offset printing and digital printing. Plans also include further enhancement of efficiency, extending business opportunities, and delivering new value in the commercial printing industry. The seamless hybrid workflows will be achieved by improving data exchange between Screen GA's Equios and the Accurio portfolio of Konica Minolta. The companies have improved data exchange in the Job Definition Format between the Equios universal workflow systems and the Accurio inkjet and toner digital presses. The improved data : exchange allows users to directly carry out digital printing from the Equios, achieving seamless operation that features colour management and finishing. The solution increases commercial printing efficiency in a production; environment and provides new business opportunities by taking full advantage of ondemand printing. Screen GA business development division head and corporate officer Toru Kawada said the company has continuously improved the Equios universal workflow systems that combine CTP workflow systems with cutting-edge inkjet printing technologies.